In a therapeutic area as complex and competitive as obesity, understanding what to measure, and why, is key to success. This insight brief from IQVIA's experts, outlines how to use COAs to capture meaningful patient data, address comorbidities, and shape a development strategy that stands out. Download now.
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
.svg){kind=icon}
